MLA
Iles, K.A, et al. Bridging Endocrine Therapy for Hr+/her2- Resectable Breast Cancer: Is it Safe?. SAGE Publications Inc., 2021. https://doi.org/10.17615/mmw7-9v67
APA
Iles, K., Thornton, M., Park, J., Roberson, M., Spanheimer, P., Ollila, D., & Gallagher, K. (2021). Bridging Endocrine Therapy for HR+/HER2- Resectable Breast Cancer: Is it Safe?. SAGE Publications Inc. https://doi.org/10.17615/mmw7-9v67
Chicago
Iles, K.A., M Thornton, J Park, M Roberson, P.M Spanheimer, D.W Ollila, and K Gallagher. 2021. Bridging Endocrine Therapy for Hr+/her2 Resectable Breast Cancer: Is it Safe?. SAGE Publications Inc.. https://doi.org/10.17615/mmw7-9v67